Cover Image
市場調查報告書

全球產前診斷市場:分析及預測

Global Prenatal Testing Market: Analysis & Forecast 2016-2022

出版商 BIS Research 商品編碼 372004
出版日期 內容資訊 英文 177 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球產前診斷市場:分析及預測 Global Prenatal Testing Market: Analysis & Forecast 2016-2022
出版日期: 2016年09月28日 內容資訊: 英文 177 Pages
簡介

本報告提供全球產前診斷市場相關調查,市場概要與產業趨勢,今後的預測,各地區,檢驗各方法趨勢,及產業的主要參與企業簡介彙整。

第1章 調查範圍和調查方法

第2章 產前診斷市場簡介

第3章 市場趨勢

  • 推動市場的要素
  • 市場課題
  • 市場機會

第4章 競爭趨勢

  • 主要市場的發展與策略
  • 產業的魅力度

第5章 產業分析

  • 專利分析
  • 國際集團,聯合,法律規章團體
  • 價值鏈分析

第6章 全球產前診斷市場:分析與預測

  • 分析與預測的假設與限制
  • 市場概要
  • 各篩檢方法市場
    • 非侵入性產前診斷
    • 其他檢驗
  • 全球各診斷方法市場
    • 各檢驗類型市場
    • 各地區市場

第7章 企業簡介

  • Agilent Technologies
  • CombiMatrix
  • Illumina Inc.
  • LabCorp Of America
  • Natera Inc.
  • Quest Diagnostics
  • Roche Holding
  • Sequenom Inc.
  • Snapshot of Some Players
  • 其他值得注意的企業

圖表

目錄
Product Code: MD10

With the emergence of advanced technologies such as next generation sequencing, high throughput screening (HTS), and cell free fetal DNA, there has been a rise in the overall demand of the newly developed prenatal testing. Presently, the government bodies are focused mainly towards development of non-invasive solutions, launching a large number of screening programs, controlling the increasing cases of genetic disorders, and integrating advanced technologies to fulfill the unmet needs of the patients.

Governmental regulations and standards are playing a major role in sustaining the growth and development of the market. The main aim of these regulations is to make prenatal tests and solutions more adaptable and focused towards effective diagnosis of various genetic disorders & chromosomal abnormalities. The patients benefit indirectly through these regulations as it helps them save time and cuts-down the overall cost as the patients receive accurate and proper testing and diagnosis of the disease.

This study includes an overview and analysis of the prenatal testing market, by type of tests, techniques, and geographical regions, allowing the research to develop a comprehensive outlook of the market. The prenatal testing market report presents a detailed analysis of market dynamics and provides an extensive insight into the various forms of development, trends, and key participants. All of the above mentioned report coverage parameters are discussed across different regions like North America, Europe, Asia Pacific (APAC), and Rest of the World (ROW) and further subdivided into major countries of each region. For report coverage and primaries, we have contacted industry experts and consultants in countries like U.S., U.K., Spain, China, India, Germany, Spain, France and Italy among others.

The answers to the following key questions can be found in the report:

  • What are the major market drivers, challenges and opportunities of the prenatal testing market and their use cases?
  • What are the key trends and developments in the prenatal testing market for genetic disease management?
  • What are the key developmental strategies in different applications across all regions?
  • What are the different types of prenatal tests and the latest technologies entering the market?
  • How will the key market players leverage on key developments such as mergers and acquisitions, partnerships, and product launches among others?
  • Which geographical region will lead the global prenatal testing market by the end of the forecast period?
  • Who are the key players in the global prenatal testing market?
  • What are the key government regulations for different prenatal tests and techniques?
  • What are the recent key market trends and key developments in different geographical regions?
  • What types of non-invasive and invasive prenatal screening tests are performed during a pregnancy?
  • What is the global and regional market for prenatal tests, through forecast period?
  • What is the global and regional market for NIPTs through 2022?
  • What is the status of prenatal testing in developed, developing and other countries?

While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, compliances, and regulatory bodies, as well as their involvement in the prenatal testing market. The research incorporates Porter's five force model for an in-depth analysis of the prenatal testing market and an assessment of the factors governing the same. The analysis builds on a well-compiled value chain, giving a detailed understanding of the ecosystem players and their rate of market penetration.

The report includes the profiles of major players in the prenatal testing market that allows the readers to gain an insight into the various industry trends.

Executive Summary

Prenatal testing is a series of preventive measure tests performed on expectant mothers to screen and diagnose genetic disorder in foetuses through gene mapping and sequencing of fetal cells. There are various factors that contribute towards the growth of the market for prenatal testing, such as: advanced maternal age, previous child with a chromosome abnormality, family history of chromosome abnormality, family history of single gene disorders, family history of neural tube defect and congenital structural abnormalities, abnormalities identified during pregnancy among others.

New technologies such as NGS, PCR, FISH, microarray, aCGH and MSS among others are becoming popular in the prenatal diagnosis and screening market. Evolving government initiatives, adoption by physicians, incorporation of tests into clinical care and allocation of reimbursement policies towards more genetic testing coverage are some of the major reasons which are driving the market. High pricing of screening and diagnostic tests along with the risk of accuracy causes hindrances in the growth of the market. In developing countries, most of the people do not have sufficient monetary resources for undergoing these expensive tests.

The global prenatal testing market is growing at a CAGR of 28.85% from 2016 to 2022 and is estimated to grow over $7.2 billion by 2022. Prenatal tests are classified into two main categories viz. Screening and Diagnostics. Both screening and diagnostics have witnessed an exponential growth in procuring treatments for disorders which increased in the past two decades. Screening prenatal tests are further divided into Non-Invasive Prenatal Testing Screening (NIPT) and other screening processes such as Cell-Free Foetal DNA (cffDNA), Maternal Serum Screening (MSS), Nuchal Scan (NT Procedure), Triple Test, and Quadruple Test.

The diagnostics market is further divided into two categories viz. Invasive and Non-Invasive. Invasive testing is a conventional technology amongst prenatal techniques because of which it is still leading the market. Due to low cost, invasive testing is preferred by people in developing countries, whereas the non-invasive is costly as well as comparatively a more recent technology which will take time to gain popularity. Non-invasive techniques cause no harm to the human body and thus are gaining preference amongst patients in developed regions around the world.

The U.S., the U.K., Japan, and India show a dynamic growth in the overall market due to an increasing prevalence of genetic disorders in these countries. The APAC region is focusing more on technological development and introduction of advanced tools in the field of prenatal and newborn care in order to develop specific tests and solutions.

Table of Contents

Executive Summary

1 Research Scope and Methodology

  • 1.1 Scope of the Report
  • 1.2 Global Prenatal Testing Market Research Methodology
    • 1.2.1 Primary Data Sources
    • 1.2.2 Secondary Data Sources

2 Introduction to the Prenatal Testing Market

3 Market Dynamics

  • 3.1 Market Drivers
    • 3.1.1 Emphasis on Early Detection and Prevention
    • 3.1.2 Increasing Genetic and Congenital Disorders
    • 3.1.3 Availability of Advanced Diagnosis and Screening Technologies
    • 3.1.4 Evolving Government Initiatives
    • 3.1.5 Adoption by Physicians: Incorporation of Tests into Clinical Care
    • 3.1.6 Shifting of Reimbursement Policies towards more Genetics Coverage
  • 3.2 Market Challenges
    • 3.2.1 Risk of Ethical Issues and Social Stigma
    • 3.2.2 Lack of Awareness among Consumers
    • 3.2.3 High Cost of Screening and Diagnosis along with the Lack of Accuracy
  • 3.3 Market Opportunities
    • 3.3.1 Availability of Direct to Consumer Tests
    • 3.3.2 Focus Toward Pre-Implantation Genetic Diagnosis

4 Competitive Insights

  • 4.1 Key Market Developments & Strategies
    • 4.1.1 New Product Launch, Development and Expansion
    • 4.1.2 Acquisitions, Partnerships and Collaborations
    • 4.1.3 Business Expansion and Others
  • 4.2 Industry Attractiveness

5 Industry Analysis

  • 5.1 Patent Analysis
  • 5.2 Consortiums, Alliances and Regulatory Bodies
  • 5.3 Value Chain Analysis

6 Global Prenatal Testing Market, Analysis & Forecast

  • 6.1 Assumptions & Limitations for Analysis and Forecast of the Global Prenatal Testing Market
  • 6.2 Market Overview
  • 6.3 Global Prenatal Testing Market by Screening Methods
    • 6.3.1 Non-Invasive Prenatal Tests (NIPT)
      • 6.3.1.1 NIPT Market by Geography
      • 6.3.1.2 North America NIPT Market
        • 6.3.1.2.1 Market Share Analysis by Countries
          • 6.3.1.2.1.1 The U.S.
          • 6.3.1.2.1.2 Canada
          • 6.3.1.2.1.3 Mexico
      • 6.3.1.3 Europe NIPT Market
        • 6.3.1.3.1 Market Share Analysis by Countries
          • 6.3.1.3.1.1 Germany
          • 6.3.1.3.1.2 France
          • 6.3.1.3.1.3 Italy
          • 6.3.1.3.1.4 U.K.
          • 6.3.1.3.1.5 Spain
          • 6.3.1.3.1.6 Other European Countries
      • 6.3.1.4 APAC NIPT Market:
        • 6.3.1.4.1 Market Share Analysis by Countries
          • 6.3.1.4.1.1 China
          • 6.3.1.4.1.2 India
          • 6.3.1.4.1.3 Japan
          • 6.3.1.4.1.4 Other APAC Countries
      • 6.3.1.5 Rest of the World NIPT Market
    • 6.3.2 Other Prenatal Screening Tests
      • 6.3.2.1 Cell-Free Fetal DNA Test
      • 6.3.2.2 Maternal Serum Screening (MSS)
      • 6.3.2.3 Nuchal Scan (NT Procedure)
      • 6.3.2.4 Triple Test
      • 6.3.2.5 Quadruple Test
  • 6.4 Global Prenatal Testing Market by Diagnosis Methods
    • 6.4.1 Global Prenatal Diagnosis Market by Test Type
      • 6.4.1.1 Non-Invasive Prenatal Diagnosis Market
        • 6.4.1.1.1 Ultrasonography
        • 6.4.1.1.2 Fetal Cells in Maternal Blood (FCMB)
        • 6.4.1.1.3 Pre-Implantation Genetic Diagnosis
      • 6.4.1.2 Invasive Prenatal Diagnosis Market
        • 6.4.1.2.1 Invasive Test Market by Test Types
          • 6.4.1.2.1.1 Amniocentesis
          • 6.4.1.2.1.2 Chorionic Villus Sampling (CVS)
          • 6.4.1.2.1.3 Other Invasive Tests
            • 6.4.1.2.1.3.1 Fetal Blood Sampling (FBS)
            • 6.4.1.2.1.3.2 Transcervical Retrieval of Trophoblast Cells
            • 6.4.1.2.1.3.3 Embryoscopy and Fetoscopy
        • 6.4.1.2.2 Invasive Test Market by Geography
          • 6.4.1.2.2.1 North America Invasive Test Market
            • 6.4.1.2.2.1.1 Market Share Analysis by Countries
              • 6.4.1.2.2.1.1.1 The U.S.
              • 6.4.1.2.2.1.1.2 Canada
              • 6.4.1.2.2.1.1.3 Mexico
          • 6.4.1.2.2.2 Europe Invasive Test Market
            • 6.4.1.2.2.2.1 Market Share Analysis by Countries
              • 6.4.1.2.2.2.1.1 Germany
              • 6.4.1.2.2.2.1.2 France
              • 6.4.1.2.2.2.1.3 Italy
              • 6.4.1.2.2.2.1.4 U.K.
              • 6.4.1.2.2.2.1.5 Spain
              • 6.4.1.2.2.2.1.6 Other European Countries
          • 6.4.1.2.2.3 APAC Invasive Test Market
            • 6.4.1.2.2.3.1 Market Share Analysis by Countries
              • 6.4.1.2.2.3.1.1 China
              • 6.4.1.2.2.3.1.2 India
              • 6.4.1.2.2.3.1.3 Japan
              • 6.4.1.2.2.3.1.4 Other APAC Countries
          • 6.4.1.2.2.4 Rest of the World Invasive Test Market
    • 6.4.2 Global Prenatal Diagnosis Market by Geography
      • 6.4.2.1 North America
        • 6.4.2.1.1 Market Analysis by Country
      • 6.4.2.2 Europe
        • 6.4.2.2.1 Market Analysis by Country
      • 6.4.2.3 APAC
        • 6.4.2.3.1 Market Analysis by Country
      • 6.4.2.4 Rest of the World (RoW)

7 Company Profiles

  • 7.1 Agilent Technologies
    • 7.1.1 Overview
    • 7.1.2 Financials
    • 7.1.2.1 Financial Summary
    • 7.1.3 SWOT Analysis
  • 7.2 CombiMatrix
    • 7.2.1 Overview
    • 7.2.2 Financials
    • 7.2.2.1 Financial Summary
    • 7.2.3 SWOT Analysis
  • 7.3 Illumina Inc.
    • 7.3.1 Overview
    • 7.3.2 Financials
    • 7.3.2.1 Financial Summary
    • 7.3.3 SWOT Analysis
  • 7.4 LabCorp Of America
    • 7.4.1 Overview
    • 7.4.2 Financials
    • 7.4.2.1 Financial Summary
    • 7.4.3 SWOT Analysis
  • 7.5 Natera Inc.
    • 7.5.1 Overview
    • 7.5.2 Financials
      • 7.5.2.1 Financial Summary
    • 7.5.3 SWOT Analysis
  • 7.6 Quest Diagnostics
    • 7.6.1 Overview
    • 7.6.2 Financials
      • 7.6.2.1 Financial Summary
    • 7.6.3 SWOT Analysis
  • 7.7 Roche Holding
    • 7.7.1 Overview
    • 7.7.2 Ariosa Diagnostics
      • 7.7.2.1 Overview
    • 7.7.3 Financials
      • 7.7.3.1 Financial Summary
    • 7.7.4 SWOT Analysis
  • 7.8 Sequenom Inc.
    • 7.8.1 Overview
    • 7.8.2 Financials
      • 7.8.2.1 Financial Summary
    • 7.8.3 SWOT Analysis
  • 7.9 Snapshot of Some Players
    • 7.9.1 Affymetrix, Inc.
    • 7.9.2 Annoroad Diagnostics
    • 7.9.3 Berry Genomics
    • 7.9.4 BGI Diagnostics
    • 7.9.5 Progenity
  • 7.10 List of Other Prominent Players

List of Tables

  • Table 2.1 Types of Genetic Diseases in Fetuses: An Overview
  • Table 2.2 Prenatal Testing: Key Technologies
  • Table 3.1 Live Birth Rate- Risk of Genetic Abnormality/ Disorders by Maternal Age
  • Table 3.2 Average Cost of Non-Invasive Prenatal Test (NIPT)
  • Table 4.1 New Product Launch, Development and Expansion
  • Table 4.2 Recent Acquisitions, Partnerships and Collaborations
  • Table 4.3 Recent Business Expansion and Others
  • Table 4.4 Key Factors Considered for Threat of New Entrants: Prenatal Testing
  • Table 4.5 Key Factors Affecting Bargaining Power of Buyers: Prenatal Testing
  • Table 4.6 Key Factors Affecting the Bargaining Power of Suppliers: Prenatal Testing
  • Table 4.7 Key Factors Affecting Threat of Substitute Products: Prenatal Testing
  • Table 4.8 Key Factors Determining Rivalry among Existing Firms: Prenatal Testing
  • Table 5.1 Example of Some Recent Patents
  • Table 5.2 Example of Some Regulatory Bodies/ Associations/Consortium
  • Table 6.1 Global Prenatal Screening Market Size, by Test Type, 2015-2022,
  • Table 6.2 Geographical Analysis of Players and Cost of NIPT
  • Table 6.3 Global NIPT Screening Market Size, by Geography, 2015-2022,
  • Table 6.4 NIPT: Recent Key Developments
  • Table 6.5 Amniocentesis Prenatal Testing Method Snapshot
  • Table 6.6 North America Prenatal Diagnosis Market Scope Statistics
  • Table 6.7 North America: Prenatal Diagnosis Market, by Test Type, 2015-2022
  • Table 6.8 Recent Key Developments in North America
  • Table 6.9 Europe Prenatal Diagnosis Market Scope Stats
  • Table 6.10 Europe: Prenatal Diagnosis Market, by Test Type, 2015-2022
  • Table 6.11 APAC Prenatal Diagnosis Market Scope Stats
  • Table 6.12 APAC: Prenatal Diagnosis Market, by Test Type, 2015-2022
  • Table 6.13 Recent Key Developments in APAC
  • Table 6.14 RoW: Prenatal Diagnosis Market, by Test Type, 2015-2022
  • Table 6.15 RoW Prenatal Diagnosis Market Scope Stats
  • Table 7.1 Snapshot of Other Key Players
  • Table 7.2 List of other Prominent Players

List of Figure

  • Figure 1 Global Prenatal Testing Market Size, 2015- 2022 ($Billion)
  • Figure 2 Global Prenatal Testing Market Size, by Type, 2015-2022 ($billion)
  • Figure 3 Global Prenatal Diagnosis Market, by Geography, 2015 and 2022 ($Billion)
  • Figure 1.1 Global Prenatal Testing Market Scope
  • Figure 1.2 Research Methodology
  • Figure 2.1 Prenatal Testing: Key Elements Covered
  • Figure 2.2 History & Evaluation of Prenatal Testing
  • Figure 2.3 Prenatal Testing Timeline during Pregnancy (Till Second Trimester)
  • Figure 2.4 Factors Responsible for Prenatal Testing
  • Figure 3.1 Market Dynamics for Prenatal Testing
  • Figure 3.2 Prenatal Testing Market: Key Market Drivers
  • Figure 3.3 Prenatal Testing: Key Challenges
  • Figure 3.4 Prenatal Testing: Key Opportunities
  • Figure 4.1 Recent Market Development Strategy Snapshot Analysis
  • Figure 4.2 Key Market Developments & Strategies
  • Figure 4.3 Porter's Five Forces Analysis
  • Figure 5.1 Value Chain Analysis
  • Figure 6.1 Classification of Global Prenatal Testing Market
  • Figure 6.2 Global Prenatal Testing Market: Opportunity Matrix
  • Figure 6.3 Global Prenatal Testing Market, by Technique 2015-2022 ($Billion)
  • Figure 6.4 Example of a Screening Method
  • Figure 6.5 Global Prenatal Screening Market Size, 2015-2022, ($Billion)
  • Figure 6.6 Prenatal Screening Methods
  • Figure 6.7 NIPT Pricing and Market Penetration Analysis
  • Figure 6.8 NIPT Pricing and Market Size
  • Figure 6.9 North America: NIPT Market by Countries, 2015-2022 ($Million)
  • Figure 6.10 The U.S. NIPT Market, 2015-2022 ($Million)
  • Figure 6.11 Canada NIPT Market, 2015-2022 ($Million)
  • Figure 6.12 Mexico NIPT Market, 2015-2022 ($Million)
  • Figure 6.13 Europe: NIPT Market by Countries, 2015- 2022 ($Million)
  • Figure 6.14 Germany NIPT Market, 2015-2022 ($Million)
  • Figure 6.15 France NIPT Market, 2015-2022 ($Million)
  • Figure 6.16 Italy NIPT Market, 2015-2022 ($Million)
  • Figure 6.17 U.K. NIPT Market, 2015-2022 ($Million)
  • Figure 6.18 Spain NIPT Market, 2015-2022 ($Million)
  • Figure 6.19 Other European Countries NIPT Market, 2015-2022 ($Million)
  • Figure 6.20 APAC: NIPT Market by Countries, 2015- 2022 ($Million)
  • Figure 6.21 China NIPT Market, 2015-2022 ($Million)
  • Figure 6.22 Indian NIPT Market, 2015-2022 ($Million)
  • Figure 6.23 Japan NIPT Market, 2015-2022 ($Million)
  • Figure 6.24 Other APAC Countries NIPT Market, 2015- 2022 ($Million)
  • Figure 6.25 ROW NIPT Market, 2015-2022 ($Million)
  • Figure 6.26 Global Others Screening Test Market, 2015-2022 ($Billion)
  • Figure 6.27 Factors Responsible for Cell-Free Fatal DNA
  • Figure 6.28 Cell-Free Fatal DNA Test; Suggested Time for Testing
  • Figure 6.29 Prenatal Diagnosis Benefits
  • Figure 6.30 Global Prenatal Diagnosis Market Size, 2015-2022, ($Billion)
  • Figure 6.31 Prenatal Diagnosis Market by Test Type
  • Figure 6.32 Global Prenatal Diagnosis Market Share, by Test Type, 2015
  • Figure 6.33 Global Non-Invasive Prenatal Diagnosis Market, 2015-2022 ($Million)
  • Figure 6.34 Global Invasive Prenatal Diagnosis Test Market, by Test type, 2015-2022 ($Million)
  • Figure 6.35 Amniocentesis Schematic Diagram6
  • Figure 6.36 Types of procedure for CVS
  • Figure 6.37 Types of Chorionic Villus Sampling (CVS) Procedure
  • Figure 6.38 Methods of Transcervical Cell collection
  • Figure 6.39 Global Invasive Prenatal Diagnosis Test Market, by Geography, 2015-2022 ($Million)
  • Figure 6.40 North America: Invasive test Market by Countries, 2015-2022 ($Million)
  • Figure 6.41 The U.S. Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.42 Canada Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.43 Mexico Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.44 Europe: Invasive Test Market by Countries, 2015-2022 ($Million)
  • Figure 6.45 Germany Invasive Test Market, 2015- 2022 ($Million)
  • Figure 6.46 France Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.47 Italy Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.48 U.K. Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.49 Spain Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.50 Other European Countries Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.51 APAC: Invasive Test Market by Countries, 2015-2022 ($Million)
  • Figure 6.52 China Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.53 India Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.54 Japan Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.55 Other APAC Countries Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.56 ROW Invasive Test Market, 2015-2022 ($Million)
  • Figure 6.57 Global Prenatal Diagnosis Market by Geography
  • Figure 6.58 Global Prenatal Diagnosis Market, by Geography, 2015-2022 ($Million)
  • Figure 6.59 North American Market Dynamics Figure 6.60 Key Players in North American Prenatal Testing Market
  • Figure 6.61 Key Factors Driving the Prenatal Testing Market in Europe
  • Figure 6.62 Key Players in European Prenatal Testing Market Figure 6.63 Key Factors Driving the Prenatal Testing Market in APAC
  • Figure 6.64 Challenges for Prenatal Testing in APAC
  • Figure 6.65 Key Players in APAC Prenatal Testing Market
  • Figure 6.66 Key Factors Driving the Prenatal Testing Market in Row
  • Figure 6.67 Key Players in RoW Prenatal Testing Market
  • Figure 7.1 Agilent: Overall Financials, 2013-2015
  • Figure 7.2 Agilent: Net Revenue by Business Segment, 2013-2015
  • Figure 7.3 Agilent: Revenue across Different Geographies, 2013-2015
  • Figure 7.4 Agilent: SWOT Analysis
  • Figure 7.5 CombiMatrix: Overall Financials, 2013-2015
  • Figure 7.6 CombiMatrix: SWOT Analysis
  • Figure 7.7 Illumina: Overall Financials, 2013-2015
  • Figure 7.8 Illumina: Net Revenue by Business Segment, 2013-2015
  • Figure 7.9 Illumina: Revenue across Different Geographies, 2013-2015
  • Figure 7.10 Illumina: SWOT Analysis
  • Figure 7.11 LabCorp: Overall Financials, 2013-2015
  • Figure 7.12 LabCorp: Net Revenue by Business Segment, 2013-2015
  • Figure 7.13 LABCORP: SWOT Analysis
  • Figure 7.14 Natera Inc.: Overall Financials, 2013-2015
  • Figure 7.15 Natera Inc.: Revenue across Different Geographies, 2013-2015
  • Figure 7.16 Natera Inc.: SWOT Analysis
  • Figure 7.17 Quest Diagnostics: Overall Financials, 2013-2015
  • Figure 7.18 Quest Diagnostics: Net Revenue by Business Segments, 2013-2015
  • Figure 7.19 Quest Diagnostics: SWOT Analysis
  • Figure 7.20 Roche Holding: Overall Financials, 2013- 2015
  • Figure 7.21 Roche Holding: Net Revenue by Business Segments, 2013-2015
  • Figure 7.22 Roche Holding: Revenue across Different Geographies, 2013-2015
  • Figure 7.23 Roche Holding: SWOT Analysis
  • Figure 7.24 Sequenom Inc.: Overall Financials, 2013- 2015
  • Figure 7.25 Sequenom Inc.: Net Revenue by Business Segments, 2013-2015
  • Figure 7.26 Sequenom Inc.: SWOT Analysis
Back to Top